Cariprazine Approved for Treatment of Depressive Episodes in BPD - MD Magazine

Submitted by Anonymous (not verified) on Tue, 05/28/2019 - 13:49

Cariprazine Approved for Treatment of Depressive Episodes in BPD  MD MagazineAllergan announced the FDA approved a New Drug Application for Vraylar for the treatment of depressive episodes associated with bipolar depression.